Vigene Biosciences secures growth capital financing

Rockville-based Vigene Biosciences Inc. a provider of viral vector products and services used in gene therapy, has completed a substantial growth capital financing transaction with Signet Healthcare Partners ("Signet"), a New York-based growth equity firm specializing in health care investments. The growth capital will be used to support Vigene's expansion into a new facility to support the ...

To purchase a reprint of this article, contact reprints@thedailyrecord.com.